GlobeNewswire Inc.··Rosen Law FirmVistagen Therapeutics Faces Securities Class Action Over Drug Trial Disclosure Allegations
Rosen Law Firm announces March 16, 2026 deadline for investors to join securities class action against Vistagen Therapeutics ($VTGN) over alleged misleading statements regarding fasedienol drug trial.
VTGNsecurities class actionmisleading statements